No Data
Kangwei Century: 2024 Annual Results Pre-loss Announcement
2024 Annual Results Advance Loss Announcement
Kangwei Century (688426.SH): Expected net loss in 2024 is between 0.142 billion yuan and -0.17 billion yuan.
Gelonghui, January 15th丨Kangwei Century (688426.SH) announced that according to preliminary calculations by the finance department, the company is expected to incur a loss in net income attributable to the owners of the parent company for the year 2024 compared to the same period last year, with a net income of -142 million yuan to -170 million yuan, representing a decrease of 68.23% to 101.40% compared to the same period last year. The net income attributable to the owners of the parent company, after excluding non-recurring gains and losses, is expected to be -166 million yuan to 194 million yuan, which represents a decrease of 38.92% to 62.35% compared to the same period last year.
Kangwei Century (688426.SH): The nucleic acid test kits for Type A/B influenza and respiratory syncytial virus have obtained the Class III medical instruments registration certificate.
Glonghui January 13丨Kangwei Century (688426.SH) announced that its wholly-owned subsidiary Jiangsu Jianwei Diagnostic Technology Co., Ltd. has independently developed and produced a nucleic acid detection kit for Type A/B influenza and respiratory syncytial virus (fluorescent PCR method), which has received a Class III "medical instruments registration certificate" issued by the National Medical Products Administration. The certificate obtained by Jianwei Diagnostics for its independently developed production of the nucleic acid detection kit for Type A/B influenza and respiratory syncytial virus is another Class III registration certificate for the company's respiratory virus testing Business. Currently, common methods for detecting respiratory viruses in China include nucleic acid testing and multiplex ...
Kangwei Century (688426.SH): Chief Financial Officer Hao Chaofeng has resigned.
Kangwei Century (688426.SH) released a notice, the company's Board of Directors received a report from the company's Deputy General Manager and Chief Financial Officer, Hao Chaofeng...
Kang Wei Century (688426.SH): The 'Kangwei Century Marketing Network Construction Project' has been extended to December 31, 2026.
Kangwei Century (688426.SH) announced on December 4 that the company's second board of directors twelfth meeting and second board of supervisors eleventh meeting held on December 4, 2024 respectively, reviewed and passed the "Proposal on the Postponement of Some Raised Investment Projects", agreed that the expected time for the use of the "Kang Wei Century Marketing Network Construction Project", one of the investment projects funded by the company, will be extended from December 31, 2024, to December 31, 2026. This extension only involves changes in project progress and does not alter the implementation subject, the use of funds raised for investment, and investment rules of the raised investment project.
Jiangsu CoWin Biotech Co., Ltd.'s (SHSE:688426) 37% Share Price Plunge Could Signal Some Risk
